ArticleScientific data2025
Histological Hyperspectral Breast Cancer Recurrence Database (HistologyHSI-BC Recurrence).
Article in Scientific data, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
Abstract
Metastasis occurs in nearly 1 out of 3 breast cancer (BC) patients and significantly reduces survival rates, particularly in cases of distant metastases. As most distant metastases develop after diagnosis (i.e., recurrence) and remain incurable, there is a critical need for prognostic biomarkers to assess recurrence risk. Multimodal data analysis has emerged as a promising approach to integrate diverse information, offering a more comprehensive perspective. This study introduces the Histology HSI-BC (hyperspectral imaging - breast cancer) Recurrence Database, the first publicly accessible multimodal database designed to advance BC distant recurrence prediction. The database comprises 47 histopathological whole-slide images, 677 hyperspectral (HS) images, and clinical and demographic data from 47 BC patients, of whom 22 (47%) experienced distant recurrence over a 12-year follow-up. Histopathological slides were digitized using a whole-slide scanner and annotated by expert pathologists, while HS images were acquired with an HS camera coupled to a bright-field microscope. This database provides a promising resource for studying BC recurrence prediction and personalized treatment strategies by integrating the aforementioned multimodal data.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.